Skip to main content

NeoGenomics Nabs Cancer Testing Contract With HealthTrust Purchasing Group

NEW YORK – NeoGenomics announced Monday that it has been awarded a three-year contract to serve as the cornerstone laboratory for HealthTrust Purchasing Group's Specialized Reference Laboratory for Oncology & Cancer Genetics.

Financial and other terms of the deal were not disclosed.

The agreement, which went into effect March 1, secures standardized corporate pricing for HPG-affiliated facilities and providers across the US and provides access to NeoGenomics' cancer diagnostic and oncology genetics testing services.

Fort Myers, Florida-based NeoGenomics is the first specialized oncology laboratory to become a preferred in-network lab option for HPG members, said CEO and Chairman Douglas VanOort in a statement.